Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

Phase 2

Completed

Conditions: Cancer
Prostate Neoplasms

Interventions: Drug: goserelin with dutasteride
Drug: goserelin with bicalutamide and dutasteride
Drug: goserelin with bicalutamide and dutasteride and ketoconazole

First Posted Date: 2006-03-01

Last Posted Date: 2018-08-09

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT00298155

Locations: 🇺🇸
Veterans' Administration Puget Sound Health Care System (VAPSHCS), Seattle, Washington, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Exisulind
Drug: luteinizing hormone-releasing hormone (LHRH) agonist
Drug: Antiandrogen

First Posted Date: 2006-01-30

Last Posted Date: 2018-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 32

Registration Number: NCT00283803

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: docetaxel
Drug: IL2

First Posted Date: 2006-01-30

Last Posted Date: 2007-11-29

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT00283829

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

Not Applicable

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2006-01-13

Last Posted Date: 2019-02-27

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT00276770

Locations: 🇺🇸
University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Adherence counseling
Device: Alarm device

First Posted Date: 2006-01-09

Last Posted Date: 2012-08-27

Lead Sponsor: University of Washington

Target Recruit Count: 400

Registration Number: NCT00273780

Locations: 🇰🇪
Hope Center for Infectious Diseases, Nairobi, Kenya

Longitudinal Study of HAART, Social Networks, & Adherence

Not Applicable

Completed

Conditions: Acquired Immunodeficiency Syndrome

Interventions: Behavioral: modified directly observed therapy (mDOT)

First Posted Date: 2006-01-04

Last Posted Date: 2007-11-07

Lead Sponsor: University of Washington

Target Recruit Count: 350

Registration Number: NCT00272220

Locations: 🇲🇿
Beira Day Hosptial - Central Hospital, Beira, Sofala, Mozambique

Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury

Phase 1

Completed

Conditions: Post-Traumatic Stress Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy
Behavioral: Standard Care Control
Behavioral: Motivational Interviewing
Drug: FDA-Approved Anti-Anxiety Medications

First Posted Date: 2005-12-29

Last Posted Date: 2020-11-04

Lead Sponsor: University of Washington

Target Recruit Count: 207

Registration Number: NCT00270959

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

SMART: Somatotrophics, Memory, and Aging Research Trial

Phase 2

Completed

Conditions: Aging
Mild Cognitive Impairment

Interventions: Drug: TH9507 human growth hormone releasing hormone (GHRH)

First Posted Date: 2005-11-23

Last Posted Date: 2013-12-19

Lead Sponsor: University of Washington

Target Recruit Count: 151

Registration Number: NCT00257712

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers

Phase 2

Completed

Conditions: Dementia
Alzheimer Disease

First Posted Date: 2005-11-21

Last Posted Date: 2015-12-02

Lead Sponsor: University of Washington

Target Recruit Count: 90

Registration Number: NCT00255866

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Rush University School of Nursing, Chicago, Illinois, United States

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

Phase 2

Completed

Conditions: Prostate Cancer
Anemia

Interventions: Drug: Aranesp

First Posted Date: 2005-10-28

Last Posted Date: 2007-11-29

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00245895

Locations: 🇺🇸
Oregon Health and Sciences University, Portland, Oregon, United States
🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy